Aberrant RAG activity has recently been reported as a major source of cancer driver mutations in TEL-RUNX1 t(12;21) B-cell leukemias [32], leading us to consider whether there may be a wider role for RUNX1 in RAG mis-regulation in human leukemia/lymphomas. The gene discussed is RUNX1; the disease is lymphoma.